GlaxoSmithKline PLC Stock Forecast - Naive Prediction

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Report: 22nd of July 2020  

GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of GlaxoSmithKline PLC historical fundamentals such as revenue growth or operating cash flow patterns. Although GlaxoSmithKline PLC naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of GlaxoSmithKline PLC systematic risk associated with finding meaningful patterns of GlaxoSmithKline PLC fundamentals over time. Please check Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections.

Search Stock Forecast

GlaxoSmithKline PLC Asset Turnover is decreasing as compared to previous years. The last year's value of Asset Turnover was reported at 0.49. The current Weighted Average Shares is estimated to increase to about 5.9 B. The current Weighted Average Shares Diluted is estimated to increase to about 5.5 B.
A naive forecasting model for GlaxoSmithKline PLC is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of GlaxoSmithKline PLC value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

GlaxoSmithKline PLC Naive Prediction Price Forecast For the 12th of July 2020

Given 30 days horizon, the forecasted value of GlaxoSmithKline PLC on the next trading day is expected to be  40.07  with a mean absolute deviation of  0.39 , mean absolute percentage error of  0.24 , and the sum of the absolute errors of  24.08 

GlaxoSmithKline PLC Stock Forecast Pattern

Backtest GlaxoSmithKline PLCGlaxoSmithKline PLC Price PredictionBuy or Sell Advice 

GlaxoSmithKline PLC Forecasted Value

Market Value
11th of July 2020
Expected Value

Model Predictive Factors

AICAkaike Information Criteria116.6802
BiasArithmetic mean of the errors None
MADMean absolute deviation0.3948
MAPEMean absolute percentage error0.0095
SAESum of the absolute errors24.0822
This model is not at all useful as a medium-long range forecasting tool of GlaxoSmithKline PLC. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict GlaxoSmithKline PLC. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for GlaxoSmithKline PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Estimates (6)
LowProjected EPSHigh
LowEstimated ValueHigh
LowReal ValueHigh
Band Projection (param)
LowerMiddle BandUpper
11 Analysts
LowTarget PriceHigh

Other Forecasting Options for GlaxoSmithKline PLC

View Currently Related Equities

GlaxoSmithKline PLC Technical and Predictive Analytics

GlaxoSmithKline PLC Market Strength Events

Volatility Measures

GlaxoSmithKline PLC Risk Indicators

Did you try this?

Run Piotroski F Score Now


Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page